BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32307142)

  • 1. Analysis of Patients With Incidental Perihilar Cholangiocarcinoma: An Old and a Persistent Burden for Liver Transplantation.
    Krasnodębski M; Grąt M; Wierzchowski M; Szczęśniak M; Morawski M; Zając K; Patkowski W; Zieniewicz K
    Transplant Proc; 2020 Oct; 52(8):2507-2511. PubMed ID: 32307142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study.
    Wong M; Kim J; George B; Eriksen C; Pearson T; Robbins J; Zimmerman MA; Hong JC
    J Surg Res; 2019 Oct; 242():23-30. PubMed ID: 31059945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results.
    Friman S; Foss A; Isoniemi H; Olausson M; Höckerstedt K; Yamamoto S; Karlsen TH; Rizell M; Ericzon BG
    Scand J Gastroenterol; 2011 Mar; 46(3):370-5. PubMed ID: 21073376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.
    Ethun CG; Lopez-Aguiar AG; Anderson DJ; Adams AB; Fields RC; Doyle MB; Chapman WC; Krasnick BA; Weber SM; Mezrich JD; Salem A; Pawlik TM; Poultsides G; Tran TB; Idrees K; Isom CA; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Cardona K; Maithel SK
    Ann Surg; 2018 May; 267(5):797-805. PubMed ID: 29064885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience.
    Morris-Stiff G; Bhati C; Olliff S; Hübscher S; Gunson B; Mayer D; Mirza D; Buckels J; Bramhall SR
    Dig Surg; 2008; 25(2):126-32. PubMed ID: 18446034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study.
    Hoogwater FJH; Kuipers H; de Meijer VE; Maulat C; Muscari F; Polak WG; van Hoek B; Jézéquel C; Alwayn IPJ; Ijzermans JNM; Mohkam K; Mabrut JY; Van Vilsteren FGI; Adam JP; Chiche L; Chebaro A; Boleslawski E; Dubbeld J; Murad SD; Rayar M; Porte RJ
    BJS Open; 2023 Mar; 7(2):. PubMed ID: 37032423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsatisfactory Long-term Results of Liver Transplant in Patients With Intrahepatic Cholangiocarcinoma.
    Krasnodębski M; Grąt M; Jastrzębski M; Szczęśniak M; Morawski M; Zając K; Patkowski W; Zieniewicz K
    Transplant Proc; 2020 Oct; 52(8):2463-2467. PubMed ID: 32327261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study.
    Jansson H; Olthof PB; Bergquist A; Ligthart MAP; Nadalin S; Troisi RI; Groot Koerkamp B; Alikhanov R; Lang H; Guglielmi A; Cescon M; Jarnagin WR; Aldrighetti L; van Gulik TM; Sparrelid E;
    HPB (Oxford); 2021 Nov; 23(11):1751-1758. PubMed ID: 33975797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection.
    Groot Koerkamp B; Wiggers JK; Allen PJ; Besselink MG; Blumgart LH; Busch OR; Coelen RJ; D'Angelica MI; DeMatteo RP; Gouma DJ; Kingham TP; Jarnagin WR; van Gulik TM
    J Am Coll Surg; 2015 Dec; 221(6):1041-9. PubMed ID: 26454735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.
    Ghali P; Marotta PJ; Yoshida EM; Bain VG; Marleau D; Peltekian K; Metrakos P; Deschênes M
    Liver Transpl; 2005 Nov; 11(11):1412-6. PubMed ID: 16237695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma.
    Darwish Murad S; Kim WR; Therneau T; Gores GJ; Rosen CB; Martenson JA; Alberts SR; Heimbach JK
    Hepatology; 2012 Sep; 56(3):972-81. PubMed ID: 22290335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
    Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
    Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Transplant for Cholangiocarcinoma.
    Zamora-Valdes D; Heimbach JK
    Gastroenterol Clin North Am; 2018 Jun; 47(2):267-280. PubMed ID: 29735023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
    Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for perihilar cholangiocarcinoma from a viewpoint of age: Is it beneficial to octogenarians in an aging society?
    Akashi K; Ebata T; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Nagino M
    Surgery; 2018 Nov; 164(5):1023-1029. PubMed ID: 30082134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.